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Abstract
Background: Better knowledge of albumin kinetics is needed to define the indications for albumin use in clinical
practice. This study involved two approaches: the synthesis rate and transcapillary escape rate of albumin were
measured simultaneously at different levels of plasma albumin concentration in relation to acute inflammation and
surgery; and two different tracers were compared to determine plasma volume and the transcapillary escape rate.
Methods: Healthy volunteers (n = 10), patients with acute inflammatory abdominal disease (n = 10), and patients
undergoing elective pancreatic resection (n = 10) were studied. The albumin synthesis rate was measured by the
incorporation of deuterium-labeled phenylalanine. Plasma volume and the transcapillary escape rate were assessed
using 123I-labeled and 125I-labeled albumin.
Results: A 50 % elevated de-novo albumin synthesis rate was seen in patients with acute inflammation and marked
hypoalbuminemia, while patients with marginal hypoalbuminemia before the start of surgery had a normal albumin
synthesis rate. The transcapillary escape rate was elevated intraoperatively during the reconstructive phase of
pancreatic surgery, when plasma albumin was decreased but stable. In acute inflammation with marked
hypoalbuminemia, the transcapillary escape rate was no different from normal. 123I-labeled and 125I-labeled albumin
were found exchangeable for plasma volume determinations, but could be used only in groups of patients for the
transcapillary escape rate.
Conclusions: This observational study illustrates the limited information contained in albumin plasma
concentrations to reflect albumin kinetics. On the contrary, single measurements of the synthesis rate and/or
transcapillary escape rate of albumin obviously cannot explain the plasma level of albumin or the changes seen
in plasma albumin concentration.
Trial registration: www.clinicaltrials.gov, study number NCT01686776. Registered 13 September 2012.
Keywords: Albumin kinetics, Hypoalbuminemia, Capillary leakage
Background
Exogenous albumin is used extensively in clinical
practice, for hemodynamic stabilization and to treat
hypoalbuminemia [1]. There are controversies around
the use of exogenous albumin and aggregated evidence
in meta-analyses shows conflicting results in critically ill
patients [2–4]. To enable studies of albumin turnover in
states with relatively rapid changes in plasma albumin
concentration, it is helpful to employ techniques that
reflect both the synthesis and distribution of albumin.
To our knowledge, a report of simultaneous assessment
of both these aspects of albumin kinetics has been
published only recently [5].
Although acute catabolism and inflammation are
associated with a low plasma albumin concentration, there
is simultaneously a high synthesis rate of albumin [6, 7].
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This is in contrast to other states of hypoalbuminemia,
like malnutrition and liver failure, when there is a low
synthesis rate of albumin [8]. The albumin in-vivo synthe-
sis rate is measured quantitatively by the incorporation of
isotope-labeled amino acids into albumin. Today stable
isotopes are used for labeling. The constant infusion
method uses an infusion of a stable isotope-labeled amino
acid during 4–12 h and blood sampling during the infu-
sion period, while the flooding technique uses administra-
tion of a bolus of isotope-labeled amino acid followed by
blood sampling during 90 min [5, 9, 10].
Albumin turnover is heavily influenced by the distribution,
in which the transcapillary escape rate (TER) of albumin
plays an important role. The TER is 5 %/hour in healthy
subjects in the basal state, but increases in sepsis and follow-
ing surgery [11]. Iodine-labeled albumin is used for meas-
urement of the TER. Several different radioactive iodine
tracers with different radiation and half-lives may be utilized
[5]. In a dynamic situation it may be advantageous to make
multiple measurements over time. Repeated measurements
employing the same tracer necessitate an increase in dose.
Use of several tracers opens the possibility to keep the
radiation dose low.
This study was designed to compare plasma volume
(PV) and the TER obtained with albumin labeled with two
different radioactive tracers, 125I and 123I, to determine
whether they are exchangeable for repeated measurements
in longitudinal studies. An additional aim was to simultan-
eously assess the albumin synthesis rate and albumin TER
in clinical settings with variable plasma albumin concen-
tration, including nonstable situations. Hence albumin
kinetics was assessed in three different subject groups:
healthy volunteers (group A), patients with an acute
abdominal inflammatory state (group B), and patients
during extensive pancreatic surgery (group C).
Methods
Materials
L-ring-2H5 phenylalanine, 99 atom percent (Cambridge
Isotope Laboratories Inc., Andover MA, USA), was
dissolved in sterile water together with unlabeled phenyl-
alanine to a concentration of 20 mg/ml, 10 molar percent
excess. The solutions were prepared, filter-sterilized, and
stored in sterile 100-ml containers by APL Pharma
Specials (Huddinge, Sweden).
Commercial 125I-labeled albumin 185 kBq/ml was
purchased (Seralb-125©; IBA molecular, Gif-sur-Yvette
Cedex, France). 123I-labeled albumin was prepared in the
Department of Nuclear Medicine at Karolinska University
Hospital, Huddinge, Sweden by incubation of sodium
iodine (123I, 37 MBq/ml; Mallinckrodt Medical) with
Albunorm 200 mg/ml (Octapharma, Stockholm, Sweden)
and Pierce Iodination Beads (product number 28665;
Thermo Fisher Scientific Inc., Waltham, MA, USA), and
then filtering through a gel column for separation of free
iodine (product number 17-0851-01, PD-10 Desalting
column; Amersham Biosciences, Uppsala, Sweden). The
final preparation contained less than 2 % free iodine.
Subjects
In total, 30 subjects in three groups were studied: (group
A) 10 healthy volunteers, (group B) 10 hospitalized
surgical patients with acute inflammatory abdominal
disease and C-reactive protein > 100 mg/ml; and (group C)
10 patients undergoing elective pancreatic resection due to
suspected malignancy. Exclusion criteria in all groups were
age < 40 years (based on a recommendation by the World
Health Organization to abstain from thyroid protection at
low radio iodine doses [12]), pregnancy, and hypersensitiv-
ity to the study drug (iodinated albumin). Pregnancy tests
were performed in women < 55 years old. The nature,
purposes, and potential risks of the experimental proce-
dures were explained to the patients before obtaining their
voluntary informed consent in writing. The study protocol
conformed to the ethical guidelines of the 2008 Declaration
of Helsinki and received a-priori approval by the Ethics
Review Board in Stockholm and the Swedish Medical
Products Agency (EudraCT 2012-002638-35, July 31, 2012).
The study was also registered at www.clinicaltrials.gov, study
number NCT01686776 (September 13, 2012) and moni-
tored by Karolinska Trial Alliance.
The healthy volunteers in group A were investigated
in the postabsorptive state in the supine position. They
were allowed to drink tap water.
Group B patients were investigated lying in their beds,
receiving i.v. fluid therapy, Ringer’s acetate 1–2 ml/kg/h,
pain relief, and antibiotics when indicated. Four patients
in this group had acute cholecystitis, three patients had
acute pancreatitis, and three patients had perforated
appendicitis. Six of these patients had surgery 1–4 days
before the study procedure (three cholecystectomies,
three appendectomies). The following comorbidities
were noted: diabetes mellitus in two patients, gout in
one patient, alcohol abuse in one patient, and previous
stroke in one patient.
Six patients in group C suffered from pancreatic cancer,
two patients from intraductal papillary mucinous neo-
plasm, one patient from duodenal cancer, and one patient
from a cystic tumor in the pancreas that turned out to be
benign. The patients had a number of comorbidities apart
from their tumors: hypertension in two patients, diabetes
mellitus in one patient, atrial fibrillation in one patient,
obesity in one patient, and distal muscular dystrophy in
one patient. These patients received general anesthesia
(induction with propofol-fentanyl, maintenance with
sevoflurane-fentanyl). All patients also received an
epidural catheter and arterial and central venous lines.
Perioperative pain relief was provided with continuous
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epidural infusion of an isotonic saline solution containing
bupivacaine 1 mg/ml, fentanyl 2 μg/ml, and adrenaline
2 μg/ml (APL Pharma, Stockholm, Sweden). In this pa-
tient group the albumin synthesis measurement was per-
formed immediately after induction of general anesthesia,
and the TER measurement after removal of tumor and
hemostasis, in a stable, nonbleeding reconstructive phase
(Fig. 1c). The intraoperative fluid therapy management
was 1 ml/kg/h of isotonic buffered glucose 25 mg/ml,
Ringer’s acetate 2 ml/kg/h, and starch 2 ml/kg/h
(Volulyte®; Fresenius Kabi, Bad Homburg, Germany).
Bleeding substitution was given at the discretion of the at-
tending anesthesiologist.
Study protocol
All subjects were monitored with continuous ECG, and
pulse oximetry during albumin synthesis, PV, and TER
measurements. Groups A + B were monitored with non-
invasive blood pressure recordings, while patients in
group C were monitored with invasive arterial blood
pressure measurement and capnography.
In group A individuals, antecubital venous lines were
inserted bilaterally; one for administration of Ringer’s acet-
ate 1–2 ml/kg/h and study-drug administration, and the
other line for blood sampling. Subjects in group B already
received an infusion of Ringer’s acetate 2 ml/kg/h by a
peripheral venous line also used for study-drug adminis-
tration, and a second venous line was inserted in the
opposite arm for blood sampling. In group C patients,
catheters in use for the anesthetic procedure were used,
an arterial line for blood sampling, and a peripheral ven-
ous line for study-drug administration.
All subjects received an infusion of L-2H5 phenylalanine
(10 molar percent excess, 45 mg/kg) during 10 min and
blood samples were taken during 90 min for albumin
synthesis assessment, at 0, 5, 10, 15, 30, 50, 70, and
90 min after the start of infusion. Blood samples were cen-
trifuged at 2000 × g and plasma was kept at −80 °C until
analysis.
After the albumin synthesis assessment was com-
pleted, 123I-albumin 2 MBq and 125I-albumin 200 kBq
were injected for determination of the TER and PV in-
cluding blood sampling every 10 min for 90 min. The
total effective radiation dose for the subjects was
<0.5 mSv, which is less than 50 % of the natural back-
ground radiation during 1 year (average in Sweden:
1.1 mSv/year [13]). According to the World Health
Organization, prophylactic administration of stable
iodine is not indicated to protect the thyroid gland at
such low doses for individuals over 40 years old [12].
Transcapillary escape rate and plasma volume
determinations
Each plasma sample was analyzed in a gamma counter
(Wallac Compugamma CS1282) during 15–90 min per
sample to achieve a total of at least 10,000 counts to
keep the error caused by variability in counts measured
below 1 %. All values were then back extrapolated to the
time point when the isotope was injected into the sub-
ject. In order to calculate the PV and TER we made the
following assumptions: steady state of albumin metabol-
ism during the period of investigation (90 min); both
tracers, 123I-HSA and 125I-HSA, behave like endogenous
albumin; the extravasation rate of both tracers is
monoexponential; and the tracers are stable and their
catabolism during the period of investigation is negli-
gible. After logarithmic transformation of plasma counts
(counts per minute (cpm)) a linear regression was per-
formed. The plasma activity at t = 0 was determined
from the regression equation. PV was calculated by
Fig. 1 Plasma albumin concentration over time. a Healthy volunteers (n= 9). b Surgical patients with acute inflammation (n= 10). c Patients undergoing
pancreatic resection (n= 9). Green area, albumin synthesis measurements; gray area, measurement of the TER and PV. x axes are not linear and are different in
the three panels. In c T1 denotes the start of the reconstruction phase during surgery, 277 ± 94 min after the beginning of the surgical procedure.
Concentrations of all individual patients are given in the three panels and the median values are indicated (red line). On a group level, plasma albumin
concentration was stable in healthy subjects and patients with acute inflammation, while plasma albumin concentration decreased until the start of the
reconstruction phase during pancreatic surgery. P-albumin plasma albumin, Whipple pancreatic surgery
Komáromi et al. Critical Care  (2016) 20:370 Page 3 of 8
division of the given dose of tracer (cpm) with the
plasma activity (cpm/ml) at t = 0. The TER was assessed
from the slope of the regression line.
The three groups have very different composition con-
cerning gender and age. To make a comparison of the
PVs between the groups possible, therefore, the mea-
sured PVs are expressed in relation (%) to the calculated
ideal PV from anthropometric measures [14].
Albumin fractional and absolute synthesis rate
determinations
Measurement of the synthesis rate of albumin employing
the flooding technique with L-2H5 phenylalanine has
been described previously in detail [15]. Briefly, albumin
in plasma samples was isolated using acid ethanol
extraction, followed by extensive washing in order to re-
move traces of free phenylalanine and then hydrolysis
with HCl. After enzymatic conversion into phenylethyl-
amine, the enrichment of L-2H5 phenylalanine from
albumin hydrolysates was determined by monitoring the
ions, at m/z 180 and 183, of the t-butyldimethylsilyl
derivative of phenylethylamine in comparison with
known standards on a quadrupole gas chromatography
mass spectrometer (Agilent, Kista, Sweden). Analysis of
plasma-free phenylalanine enrichment was performed
after acid precipitation and cation-exchange chromatog-
raphy by monitoring the ions, at m/z 336 and 341, of
the t-butyldimethylsilyl derivative. The fractional synthe-
sis rate (FSR) of albumin (i.e., the fraction of intravascu-
lar albumin pool that is synthesized every day) was
determined using the formula described previously [16]:
FSR ¼ P2−P1ð Þ=AUC  100
where FSR is expressed in percent per day and P1 and
P2 represent enrichment of phenylalanine in albumin at
two time points, t1 and t2, after the curve of enrichment
becomes linear, based on three samples (50, 70, and
90 min). AUC is the area under the curve for enrich-
ment of plasma-free phenylalanine between time points
t1 and t2 adjusted for the secretion time (i.e., the tem-
poral lag period before the appearance of labeled albu-
min in plasma). The secretion time was assessed by
plotting each individual’s regression line for the linear
part of the albumin enrichment curve and extrapolating
to the baseline enrichment [16]. The absolute synthesis
rate (ASR) for albumin was calculated as the product of
the fractional rate of albumin synthesis and the intravas-
cular albumin mass, calculated from the plasma albumin
concentration and the measured PV.
Albumin concentration determinations
Blood samples for determination of plasma albumin were
spun at 2000 × g. Plasma was transferred to polypropylene
vials and frozen at −20 °C until analyzed by nephelometry
at Studiecenter Karolinska University Hospital Solna.
Statistical analysis
Data are presented as mean ± SD or median (range) as ap-
propriate by Shapiro–Wilk’s test of normality. One-way
ANOVA is used for comparison of the three groups in
terms of PV, ASR, and FSR, followed by the Bonferroni
post-hoc test for pair-wise comparisons. Kruskal–Wallis
ANOVA for three independent groups is used for the
TER, followed by two-tailed multiple comparisons of
mean ranks for all groups. Correlations are assessed using
Pearson’s coefficient of correlation. The study is powered
to be able to compare the TERs measured by albumin la-
beled with two different isotopes. With n = 10, there is an
80 % power to find a difference corresponding to an effect
size of one (the difference between paired samples divided
by the standard deviation of that difference) using a two-
sided test and alpha = 0.05 within each of the studied
groups. With a precision in the TER of 2 %/hour as
suggested [17], a similar difference of 2 %/hour will be
detected by n = 10. If all three groups are analyzed
together (n = 30), a power of 80 % is reached to detect an
effect size of 0.53, suggesting that a bias of only 1 % will
be found significant. Statistical analysis was performed
using STATISTICA 10 (Statsoft Inc, Tulsa, OK, USA).
Results
The characteristics of the subjects studied—healthy
volunteers (group A), surgical patients with acute
inflammation (group B), and patients scheduled for
pancreatic resection (group C)—are presented in Table 1.
Volunteers in group A were younger, had a lower BMI,
and had a different gender distribution compared with
groups B and C. In group C the median (range) intraoper-
ative blood loss was 450 ml (50–1450 ml), and one patient
received 500 ml erythrocyte concentrate transfusion. In
this group, nine patients had pancreatoduodenectomy,
with one of these also having splenectomy, gastrectomy,
hemicolectomy, and aortocaval lymphadenactomy; and
one patient had enucleation of a pancreatic cyst. Because
of analytic errors, data from one subject in group A and
from one subject in group C were excluded from the PV
and TER results. Similarly because of missing samples,
data from one subject in group C were excluded from the
albumin FSR and ASR results. No subjects were excluded
for being outliers, as illustrated by the patient in group C
with a very high TER who underwent a much more
extensive and long-lasting surgical procedure than any
other subject.
As illustrated in Fig. 1, the plasma albumin concentration
was stable for groups A and B, while the plasma albumin
concentration decreased between the albumin synthesis
measurement and the TER/PV measurements in group C
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(pancreatic surgery). The time period of albumin concentra-
tion decrease started with administration of epidural
blockade and general anesthesia, and continued until the
end of the dissection part of the surgical procedure.
The albumin synthesis rates for the three different
groups are shown in Fig. 2, illustrating the elevated
albumin synthesis rate in patients with acute inflammation
as compared with the other two groups, both measured in
the basal state. Patients with acute inflammation (group
B) were different both in FSR and ASR as compared with
healthy volunteers and patients scheduled for pancreatic
surgery preoperatively (P < 0.001).
The results using two different albumin labels, 123I-albu-
min and 125I-albumin, to determine the TER and PV in the
three different groups of subjects are presented in Figs. 3
and 4, respectively, illustrating that the three groups were
different in terms of TER but not in terms of PV. Compar-
ing all of the measurements obtained using the two different
albumin labels in Bland–Altman plots (Fig. 5) gave a line of
identity for PV of 65 ml, but a statistically significant
systematic bias of 1.1 %/hour for the TER (P < 0.001, n= 28).
For PV, the confidence interval was ±10 % in the interval
2300–4700 ml. For the TER, the confidence interval was
2 % in the interval 4–11 %/h.
Discussion
This observational study illustrates the limited informa-
tion contained in the albumin plasma concentration,
when albumin kinetics is considered. The three groups
of subjects studied differ in terms of plasma concentra-
tion, synthesis rate, and TER. A “snapshot” measurement
of the albumin synthesis rate and/or TER obviously
Table 1 Characteristics of subjects
Healthy volunteers Acute inflammation Whipplea
Sex, males: females 3:7 8:2 9:1
Age (years) 50 ± 8 62 ± 13 61 ± 11
Body mass index (kg/m2) 24.4 ± 2.3 28.9 ± 3.7 26.0 ± 5.6
Plasma C-reactive protein (mg/L) 1.4 (0.9–4) 234 (106–450) 9 (0.9–44)
Plasma albumin (g/L) 39.0 ± 2.0 26.0 ± 4.6 32.8 ± 6.8
White blood cell count (109/L) 6.2 ± 0.9 13.0 ± 5.0 7.0 ± 2.3
Platelet count (109/L) 232 ± 30 232 ± 66 316 ± 120
Prothrombin time, INRb 1.0 ± 0.1 1.1 ± 0.2
Plasma creatinine (μmol/L) 71 ± 14 83 ± 26 71 ± 17
Data presented as mean ± standard deviation or median (range) as appropriate according to Shapiro-Wilk’s test of normality
aBaseline measurements
bInternational normalized ratio (INR), no units, normal range 0.8–1.2
Fig. 2 Fractional synthesis rate (FSR) and absolute synthesis rate (ASR) of albumin in healthy volunteers (n = 10, blue), in surgical patients with
acute inflammation (n = 10, red), and in patients undergoing pancreatic resection (n = 9, green) as measured by incorporation of d5-phenylalanine
into protein. Median values indicated by black lines. Patients with acute inflammation were different from the two other groups for both aspects
of the synthesis rate (P < 0.001). Whipple pancreatic surgery
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cannot explain the plasma level of albumin or the
changes seen in plasma albumin concentration.
The albumin synthesis rates for the three groups of
subjects compare well with earlier studies. Both volunteers
[15] and cholecystitis patients [6] have been investigated
previously. The temporal pattern of plasma albumin con-
centration in patients undergoing pancreatic resection
fully reproduced a previous report [18]. The impact on
the de-novo synthesis rate during anesthesia and surgery
is less well studied, however. Immediately after induction
of general anesthesia, a slight decrease in FSR by 1.1 %/
24 h is reported in patients undergoing laparoscopic
cholecystectomy [19]. The combined effect of general
anesthesia and epidural anesthesia has so far not been
characterized. In particular, the immediate effect of a
major surgical procedure, dramatically increasing the
TER, on albumin synthesis is not yet elucidated. It must
be noted that the start of the decrease in plasma albumin
concentration may initially at least partly be attributable
to a transiently expanded PV during the synthesis meas-
urement period, related to the relatively high rate of fluid
administration in accordance with the fluid protocol
Fig. 3 Transcapillary escape rate of albumin (TER) in healthy volunteers (n = 9, blue), in surgical patients with acute inflammation (n = 10, red), and
in patients undergoing pancreatic resection (n = 9, green) as measured by 123I-albumin and 125I-albumin, respectively. Median values indicated by
black lines. The TER is different during pancreatic surgery as compared with controls for both 123I-albumin and 125I-albumin. HSA human serum
albumin, Whipple pancreatic surgery
Fig. 4 Plasma volume (PV) in healthy volunteers (n = 9, blue), in surgical patients with acute inflammation (n = 10, red), and in patients undergoing
pancreatic resection (n= 9, green) as measured by 123I-albumin and 125I-albumin, respectively. To make groups more comparable the measured PVs are
related to the anthropometrically calculated PVs [14]. Median values indicated by black lines. No difference in PV between the three groups was detected.
HSA human serum albumin, Whipple pancreatic surgery
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applied. This suggestion is purely hypothetical, however,
because we did not measure PV until later, during the re-
constructive part of the surgical procedure, when it was
no different from the PV in healthy subjects or patients
with acute inflammation—although the interindividual
scatter was larger, possibly related to the differences in
fluid administration (Fig. 4).
The TER was demonstrated to be markedly elevated
already during the latter part of a major surgical procedure,
at a time point when the full decrease in plasma albumin
concentration had occurred. This finding may be interpreted
as an indication of rapid changes in the TER during at least
the early phase of generalized inflammation in response to
major surgery. Despite this, no further decrease in plasma
albumin level was seen after this time point (Fig. 1). Further
on, 48 hours postoperatively, with a similar decrease in
plasma albumin concentration, the TER is back to normal
[5, 18]. Nevertheless, our data provide new information re-
garding the relation between albumin plasma concentration
and the TER in surgical trauma. In group B a state of acute
inflammation was accompanied by a concomitant low but
stable plasma albumin concentration. However, the moder-
ate increase of the TER did not reach statistical significance
(Fig. 3). In the early phase of the inflammatory insult, these
subjects may have had a transient increase in the TER, no
longer present at the time of measurement. The TER re-
flects the escape of isotopic label from plasma, but the re-
turn of albumin to plasma, mainly through the lymphatic
system, is not easy to quantify by existing techniques in hu-
man subjects. Some information on this possible mismatch
between escape and return may be gained by utilizing calcu-
lations of fluid and albumin balances [18].
The two different radio-iodine labels of albumin gave
identical results for PV, while there was a 1.1 %/hour abso-
lute difference for the TER. This means that the two labels
are fully exchangeable for multiple PV determinations,
while the exchangeability for TER is limited to situations
when absolute differences >4– 5 % are expected. The
limits of agreement indicate a standard deviation of <10 %
in relative terms, which translates into a possibility to de-
tect differences of this magnitude with a statistical power
of 80 % in 11 subjects. The use of three different groups of
subjects with, when combined, a larger than normal range
of the TER makes this assumption valid in this wider
range (4–11 %/hour).
The differences in the TER related to the isotopic label
were most likely attributable to the presence of free label
in the preparations. Differences attributable to the differ-
ence in isotopic half-life were eliminated by the analytic
procedure used.
The strengths of this study are the inclusion of three
well-defined groups of subjects with different characteris-
tics of plasma albumin concentration, albumin synthesis
rate, and TER; and the systematic comparison of two dif-
ferent radio-iodine labels for possible use when multiple
determinations of the TER or PV are needed. The limita-
tions of the study are that there is some mismatch in an-
thropometry between the groups, and that the inclusion
criteria in the pancreatic surgery group, which also in-
cluded surgical outliers, are perhaps too pragmatic.
Conclusions
This study provides new information on the temporal
development of albumin kinetics during major abdom-
inal surgery associated with hypoalbuminemia and an in-
crease in capillary leakage. The results illustrate the
limited information contained in albumin plasma con-
centrations to reflect albumin kinetics. On the contrary,
occasional measurements of the synthesis rate and/or
TER of albumin obviously cannot explain the plasma
level of albumin or the changes seen in plasma albumin
concentration. Furthermore the possibilities to use
radio-iodine albumin for multiple assessments in studies
over albumin kinetics were explored. The labels were
found exchangeable for PV determinations, but for the
TER only in groups of patients.
Fig. 5 Bland–Altman plots demonstrating agreement between measurements of the transcapillary escape rate (TER) and plasma volume (PV) as
measured by 123I-albumin and 125I-albumin, respectively, in healthy volunteers (n = 9, blue), in surgical patients with acute inflammation (n = 10,
red), and in patients undergoing pancreatic resection (n = 9, green. Limits of agreement given as the mean difference ± 2.045 SD (n = 28, hatched
lines) and the line of identity (solid line) are shown
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Key messages
 Albumin plasma concentrations poorly reflect
albumin kinetics.
 Single measurements of the albumin synthesis rate
and/or transcapillary escape rate of albumin poorly
explain the plasma level of albumin.
 The transcapillary escape rate is elevated at the end
of a major surgical procedure.
 123I-labeled and 125I-labeled albumin are exchangeable
for plasma volume determinations, but not for
transcapillary escape rate measurements.
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